B. Heger

Co‐infection with HIV‐1/ HTLV‐II and the risk of progression to AIDS and death

A. Eskild, H. H. Samdal, B. Heger, 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: Possible implication for TLR4-signalling and chronic immune activation

T. Kanda, J. Damås, I. Lygren, 2013, Innate immunity.

The estimated impact of the CCR‐5 Δ32 gene deletion on HIV disease progression varies with study design

T. Ø. Jonassen, A. Eskild, B. Grinde, 1998 .

The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects.

P. Magnus, S. Frøland, A. Eskild, 1997, Scandinavian journal of infectious diseases.

[South American blastomycosis--a differential diagnosis to tuberculous meningitis].

B. Heger, E. Strøm, G. Syversen, 2001, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations.

J. Brinchmann, B. Heger, T. Egeland, 1994, The Journal of infectious diseases.

The estimated impact of the CCR-5 delta32 gene deletion on HIV disease progression varies with study design. Oslo HIV Cohort Study Group.

A. Eskild, B. Grinde, B. Heger, 1998, AIDS.

[Splenic atrophy and fatal pneumococcal infection in inflammatory bowel disease].

M. Rostrup, B. Heger, J. Maehlen, 1997, Tidsskrift for Den Norske Laegeforening.

[An outbreak of hepatitis A among intravenous drug addicts in Oslo 1995-96].

M. Jensenius, B. Grinde, B. Heger, 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.